BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26622592)

  • 41. Association between 5-lipoxygenase expression, and malignant behaviors and poor prognosis in esophageal squamous cell carcinoma.
    Bai CY; Zhang JY; Shi TW; Bai YQ; Wu BL; Du ZP; Wu ZY; Xu XE; Wang SH; Wu JY; Te RY; Zhang JY; Xu LY; Li EM
    Oncol Lett; 2018 Jun; 15(6):9353-9360. PubMed ID: 29805660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.
    Rossi E; Villanacci V; Danesino C; Donato F; Nascimbeni R; Bassotti G
    Rev Esp Enferm Dig; 2011 Dec; 103(12):632-9. PubMed ID: 22217347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guanylate-binding protein 1 (GBP1) promotes lymph node metastasis in human esophageal squamous cell carcinoma.
    Li L; Ma G; Jing C; Liu Z
    Discov Med; 2015 Dec; 20(112):369-78. PubMed ID: 26760981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma.
    Ren ZP; Chu XY; Xue ZQ; Zhang LB; Wen JX; Deng JQ; Hou XB
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3866-3870. PubMed ID: 28975978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    Deng F; Zhou K; Cui W; Liu D; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic and clinicopathological significance of
    Wang Y; Wu Y; Li J; Lai Y; Zhou K; Che G
    Ann Transl Med; 2019 Nov; 7(22):669. PubMed ID: 31930070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Role of AIB1 gene in development of esophageal squamous cell carcinoma and its clinicopathologic significance].
    Xu FP; Liu YH; Zhuang HG; Li L; Luo XL; Wen JM
    Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):250-4. PubMed ID: 18844034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Significance of c-MYC Amplification in Esophageal Squamous Cell Carcinoma.
    Huang J; Jiang D; Zhu T; Wang Y; Wang H; Wang Q; Tan L; Zhu H; Yao J; Hou Y
    Ann Thorac Surg; 2019 Feb; 107(2):436-443. PubMed ID: 30273571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.
    Sunpaweravong P; Sunpaweravong S; Puttawibul P; Mitarnun W; Zeng C; Barón AE; Franklin W; Said S; Varella-Garcia M
    J Cancer Res Clin Oncol; 2005 Feb; 131(2):111-9. PubMed ID: 15672286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome.
    Woelber L; Hess S; Bohlken H; Tennstedt P; Eulenburg C; Simon R; Gieseking F; Jaenicke F; Mahner S; Choschzick M
    J Clin Pathol; 2012 Feb; 65(2):133-9. PubMed ID: 22128196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma.
    Yang D; Li R; Wang H; Wang J; Li Y; Wang H; Wang W; Liu Z
    Oncol Lett; 2018 Sep; 16(3):2971-2978. PubMed ID: 30127886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
    Yang JW; Choi YL
    Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.
    Jia J; Cui Y; Lu M; Wang X; Li J; Li J; Li Y; Zhang X; Gao J; Zhou J; Lu Z; Gong J; Yu J; Sun Z; Liu C; Shen L; Zhang X
    Clin Transl Oncol; 2016 Jun; 18(6):592-8. PubMed ID: 26459251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
    Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
    Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas.
    Tang D; Liu CY; Shen D; Fan S; Su X; Ye P; Gavine PR; Yin X
    Onco Targets Ther; 2015; 8():7-14. PubMed ID: 25565860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.
    Kimura M; Tsuda H; Morita D; Shinto E; Tanimoto T; Ichikura T; Mochizuki H; Matsubara O
    Jpn J Clin Oncol; 2005 Jun; 35(6):324-31. PubMed ID: 15928192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
    Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
    Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
    Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.